Intellectus Partners’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88K | Hold |
53,312
| – | – | 0.02% | 270 |
|
|
2025
Q1 | $70.9K | Buy |
+53,312
| New | +$70.9K | 0.02% | 262 |
|
|
2024
Q4 | – | Sell |
-53,527
| Closed | -$41.5K | – | 283 |
|
|
2024
Q3 | $41.5K | Buy |
53,527
+215
| +0.4% | +$167 | 0.01% | 258 |
|
|
2024
Q2 | $40K | Sell |
53,312
-430
| -0.8% | -$323 | 0.01% | 254 |
|
|
2024
Q1 | $57K | Buy |
53,742
+215
| +0.4% | +$228 | 0.02% | 256 |
|
|
2023
Q4 | $56.2K | Hold |
53,527
| – | – | 0.02% | 241 |
|
|
2023
Q3 | $60K | Hold |
53,527
| – | – | 0.02% | 254 |
|
|
2023
Q2 | $80.6K | Buy |
+53,527
| New | +$80.6K | 0.02% | 256 |
|
|
2022
Q1 | – | Sell |
-33,169
| Closed | -$419K | – | 260 |
|
|
2021
Q4 | $419K | Sell |
33,169
-9,720
| -23% | -$123K | 0.11% | 191 |
|
|
2021
Q3 | $3.93M | Buy |
42,889
+9,439
| +28% | +$865K | 0.95% | 17 |
|
|
2021
Q2 | $1.77M | Buy |
33,450
+11,400
| +52% | +$604K | 0.4% | 62 |
|
|
2021
Q1 | $794K | Buy |
22,050
+8,100
| +58% | +$292K | 0.22% | 136 |
|
|
2020
Q4 | $388K | Buy |
13,950
+8,650
| +163% | +$241K | 0.12% | 178 |
|
|
2020
Q3 | $265K | Buy |
5,300
+100
| +2% | +$5K | 0.1% | 182 |
|
|
2020
Q2 | $241K | Buy |
+5,200
| New | +$241K | 0.09% | 190 |
|